Trial Profile
Ubenimex in Adult Patients With Lymphedema of The Lower Limb: a Phase 2, RAndomized, Double-blind, Placebo-controlled Study of Efficacy, Safety, and Pharmacokinetics (ULTRA)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Jan 2023
Price :
$35
*
At a glance
- Drugs Ubenimex (Primary)
- Indications Lymphoedema
- Focus Proof of concept; Therapeutic Use
- Acronyms ULTRA
- Sponsors Eiger BioPharmaceuticals
- 15 Jul 2019 Status changed from active, no longer recruiting to completed.
- 12 Nov 2018 Planned End Date changed from 1 Nov 2018 to 1 feb 2019.
- 16 Oct 2018 Primary endpoint (Change in skin thickness of the calf of the most affected leg, measured by skinfold calipers) has not been met.